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Bullying is a common childhood experience that involves repeated
mistreatment to improve or maintain one’s status. Victims display
long-term social, psychological, and health consequences, whereas
bullies display minimal ill effects. The aim of this study is to test
how this adverse social experience is biologically embedded to
affect short- or long-term levels of C-reactive protein (CRP), a
marker of low-grade systemic inflammation. The prospective
population-based Great Smoky Mountains Study (n = 1,420), with
up to nine waves of data per subject, was used, covering child-
hood/adolescence (ages 9–16) and young adulthood (ages 19 and
21). Structured interviews were used to assess bullying involve-
ment and relevant covariates at all childhood/adolescent observa-
tions. Blood spots were collected at each observation and assayed
for CRP levels. During childhood and adolescence, the number of
waves at which the child was bullied predicted increasing levels of
CRP. Although CRP levels rose for all participants from childhood
into adulthood, being bullied predicted greater increases in CRP
levels, whereas bullying others predicted lower increases in CRP
compared with those uninvolved in bullying. This pattern was
robust, controlling for body mass index, substance use, physical
and mental health status, and exposures to other childhood psy-
chosocial adversities. A child’s role in bullying may serve as either
a risk or a protective factor for adult low-grade inflammation,
independent of other factors. Inflammation is a physiological
response that mediates the effects of both social adversity and
dominance on decreases in health.
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The social and psychological effects of bullying involvementare independent of other childhood experiences, pleiotropic,
and long lasting, with the worst effects for those who are both
victims and bullies (e.g., refs. 1–4). To date, the primary focus
of bullying research has been on such psychosocial outcomes.
Bullied children, however, also have adverse physical health
functioning (1, 5–7), including a broad range of somatic issues,
such as sleep problems, abdominal pain, appetite suppression,
headaches, and frequency of illnesses. In contrast, there is evi-
dence to suggest that those who perpetrate only, pure bullies,
may be healthier than their peers, emotionally and physically
(6, 8). Little is known about how this social adversity becomes
biologically embedded to influence health status.
One potential mechanism is chronic systemic low-grade in-
flammation (9). Inflammation is activated similarly by a diverse
range of health risk behaviors (poor diet, lack of exercise, and
sleep disturbance) and environmental challenges [low socioeco-
nomic status (SES), psychosocial stress] (10–14). Elevated in-
flammation markers are part of the phenomenology of common
psychological disorders (particularly depression) across the life-
span (for reviews, refs. 15, 16). One marker of inflammation,
C-reactive protein (CRP), has been the focus of extensive epi-
demiologic investigation because of the association of elevated
plasma CRP levels (>3 mg/L) with cardiovascular risk (17, 18)
and aspects of metabolic syndrome (19–21). Subclinical levels of
inflammation may be a nonspecific marker for a broad range of
organismic challenges, but they have not been studied as a mech-
anism for the social adversity of bullying involvement on health.
The aim of this study was to use a prospective, longitudinal
study that has followed a sample of 1,420 children up to nine
times to test whether involvement in childhood bullying affects
low-grade inflammation as measured by CRP levels short term
within childhood/adolescence (ages 9–16) and long term into
adulthood (ages 19 and 21). Chronic victims and bully/victims
display the worst health and psychosocial outcomes (1, 2, 4). It is
hypothesized that both these groups will have more systemic
inflammation because of the social strain of victimization. Al-
most no attention has been paid to the biological consequences
to bullying itself in the absence of being a victim. Children may
use bullying techniques in efforts to elevate their social status
(22). In adults, such elevated social status, measured by income
or education level, is associated with lower levels of inflammatory
markers (23–25). The role of elevated social status inflammatory
markers has not yet been tested, but we expected that pure bullies
would display lower levels of CRP than those uninvolved in bullying.
Results
Descriptive Statistics. By age 21, 8,806 total assessments were
completed in the 1,420 study subjects. Blood spots were obtained
at 6,087 assessments (69.1%). Comparisons of observations with
versus without blood spots indicated no significant differences in
any of the bullying measures. Of the 6,087 blood spots collected,
6,001 (98.6%) were assayed successfully for CRP. Of the 1,420
study participants, 1,334 (93.9%) provided blood spot samples
assayed for CRP in 1 year or more. The median number of CRP
samples provided was 5 [mean 4.77 (SD 2.24); range 1–9].
Significance
Bullying is a common childhood experience that affects chil-
dren at all income levels and racial/ethnic groups. Being a bully
victim has long-term adverse consequences on physical and
mental health and financial functioning, but bullies themselves
display few ill effects. Here, we show that victims suffer from
greater increases in low-grade systemic inflammation from
childhood to young adulthood than are seen in others. In
contrast, bullies showed lower increases in inflammation into
adulthood compared with those uninvolved in bullying. Ele-
vated systemic low-grade inflammation is a mechanism by
which this common childhood social adversity may get under the
skin to affect adult health functioning, even many years later.
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Table 1 provides the rates of demographic and bullying vari-
ables during childhood/adolescent observations (ages 9–16) and
young adult observations (ages 19 and 21), as well as mean CRP
levels within each period. As shown previously, levels of CRP rise
from adolescence to young adulthood (26). There were no baseline
differences in CRP levels between bullying groups before bullying
involvement or based upon subsequent cumulative involvement.
Bullying Involvement and Childhood/Adolescent CRP Levels. Table 2
summarizes results from models predicting childhood/adolescent
(ages 9–16; 4,870 observations of 1,309 subjects) CRP levels
from recent bullying involvement. All models accounted for CRP
levels at the prior observation; thus, the models predict changes
in CRP levels associated with recent bullying involvement. This
simple model predicted CRP levels from bully status (dummy
coded to compare pure victims, pure bullies, and bully–victims
with those uninvolved in bullying). Subsequent models tested
whether simple associations were robust to two sets of covariates:
(i) variables associated with CRP levels [sex, age, race/ethnicity,
time since last interview, body mass index (BMI), recent nicotine
use, recent alcohol use, recent drug use, recent medication use,
health ailments, low SES] and (ii) variables associated with bul-
lying involvement (sex, low SES, family instability, family dys-
function, maltreatment, depressive disorders, anxiety disorders,
disruptive behavior disorders, or substance disorders). All models
used weighted linear regression models with robust variance
(sandwich-type) estimates to adjust for repeated observations of
each subject.
The first series of models focuses on recent bullying in-
volvement only (rows 1–4), meaning that we predicted current
CRP levels from recent bullying involvement, controlling for
previous CRP. Pure victims, pure bullies, and bully–victims
(those who both bullied others and were bullied) were compared
with those uninvolved in bullying. Neither pure bullies nor vic-
tims differed in CRP changes from those uninvolved in bullying
in simple models or in models adjusted for CRP- or bullying-
related covariates. Prior levels of CRP were the strongest pre-
dictor of current CRP levels in all models. The second series of
models (rows 5–8) looks at the effect of cumulative bullying in-
volvement over time, meaning that our bullying variable in these
analyses counted the number of assessments during which a
particular bullying involvement had been reported to date. For
example, children who had not experienced bullying at wave 1,
but had experienced it at waves 2 and 3, received a code of “0” at
wave 1, “1” at wave 2, and “2” at wave 3. Cumulative exposures
for pure victims predicted increased CRP levels in the simple
model as well as in the covariate-adjusted models. Neither
cumulative bullying nor bully–victim exposures predicted CRP
levels. Fig. 1 shows the adjusted mean CRP levels based on cu-
mulative exposures to being bullied. Tables S1 and S2 show
results separately by parent and child report.
Bullying Involvement and Young Adult CRP Levels. Table 3 sum-
marizes models predicting young adult CRP levels (ages 19–21;
1,131 observations of 759 subjects) from childhood/adolescent
bullying involvement (ages 9–16). All analyses predicting early
adult CRP levels controlled for baseline CRP levels in child-
hood; thus, these models predict changes in CRP levels that are
associated with childhood/adolescent bullying involvement from
childhood to adulthood. The first set of models (rows 1–4) ag-
gregated information about any bullying involvement in child-
hood/adolescence. For example, if a child had been bullied at
any point during ages 9–16, he or she received a code of 1 on this
variable. The second part of the table (rows 5–8) looked at the
cumulative number of childhood and adolescent observations
positive for such involvement. Similar sets of CRP- and bullying-
related covariates were used to test for robust associations,
except CRP-related covariates were measured in adulthood,
whereas bullying-related covariates accounted for childhood
hardships and psychiatric problems. Both series of models pro-
duced similar results: being a bully in childhood/adolescence
predicted lower levels of CRP in young adulthood, and being
a victim predicted higher levels of CRP compared with those
uninvolved in bullying. Bully–victims, however, did not vary from
those uninvolved in bullying. Fig. 2 shows the young adult ad-
justed mean CRP levels based on childhood/adolescent bullying
status. Furthermore, cumulative victimization (victims) in child-
hood increased CRP levels in adulthood, indicating a dose–
response. Tables S3 and S4 show results separately by parent and
child report. Analyses were rerun to compare the effect of bul-
lying involvement in childhood (ages 9–13) and adolescence
(ages 14–16) separately (Table S5). The finding of lower CRP
levels in victims was stronger in childhood and the higher CRP
levels for bullies in the adolescent analyses.
Discussion
This study leverages a prospective, longitudinal design to test
whether involvement in bullying—as bully, victim, or both—was
associated with low-grade inflammation in the short term within
childhood or long term into young adulthood. Short term, there
was a dose-dependent relation between the number of times
a child had been bullied and CRP levels. This relationship pro-
vides a potential mechanism for the observed health problems
reported for victims of bullying (1, 5, 6). Childhood bullying in-
volvement as either a pure bully or victim predicted changes in
CRP levels that lasted into adulthood. Although CRP levels rose
for all participants across this period, being bullied predicted
greater increases in CRP levels, whereas bullying others pre-
dicted lower increases in CRP compared with those uninvolved
in bullying. These long-term effects were robust to adjustment
for BMI, substance use, childhood physical and mental health
status, and exposures to other early-life psychosocial adversities.
Inflammation is a plausible mechanism by which bullying in-
volvement may affect short- and long-term health status.
The finding of greater increases in CRP levels for pure victims
is less surprising given previous evidence of short- and long-term
impaired health functioning (1, 6, 8) and associations between
childhood psychosocial adversity and inflammation levels (27,
28). At the same time, the strength of our findings rests on the
Table 1. Descriptive statistics
Variables
Childhood/adolescent
(ages 9–16)
Adulthood
(ages 19 and 21)
Subjects, n 1,309 759
Observations, % (n)
Total 4,870 1,131
Female 52.5 (2,678) 54.6 (575)
Race
White 89.7 (3,227) 89.7 (679)
American Indian 4.4 (1,386) 4.1 (399)
African American 5.9 (257) 6.2 (53)
Victims, no. of exposures
0 75.7 (3,568) 73.7 (810)
1 18.9 (950) 19.2 (213)
2 3.9 (249) 5.1 (70)
3+ 1.6 (103) 2.0 (38)
Bully, no. of exposures
0 92.1 (4,317) 88.9 (964)
1 6.8 (440) 8.9 (127)
2 1.0 (100) 1.9 (32)
3+ 0.1 (13) 0.3 (8)
Median CRP level, mg/L 0.20 0.75
Percentages are weighted, and number of observations is unweighted.
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following features of this study. First, this study was able to
control for preexisting CRP levels in all analyses, allowing us
to clarify that observed differences are not attributable to base-
line CRP differences and thus preexisting differences between
groups. Second, the prospective design allowed us to account for
a host of individual and family factors that may explain the ob-
served bullying–CRP associations. Together, these features allow
for strong inferences about the causal role of bullying in-
volvement in changing CRP level within an observation study.
Finally, bullying is different from other childhood adversities
studied. It is a relatively common experience for children and
adolescents and the most frequent form of violence experienced
outside the home (29, 30), although it still is considered by many
to be a harmless rite of passage and by others a modest, time-
limited stressor. Our findings suggest this childhood social ad-
versity may disrupt levels of inflammation well into adulthood,
similar to what is seen for early traumatic events, such as child
maltreatment (9).
Our findings of increases in CRP levels as a function of a cu-
mulative history of being bullied are consistent with changes in
hypothalamic–pituitary–adrenal axis function, particularly corti-
sol levels, reported in victims (31–36). Although not all studies
support associations between bullying and cortisol levels (see ref.
37 for null finding), a series of studies suggests that victims,
particularly those victimized over long periods, have a blunted
cortisol secretion in response to a laboratory social stress test
(35, 36), with some evidence that this effect is moderated ge-
netically (34). This provides a potential neuroendocrine mecha-
nism for our observed inflammation findings: a blunted response
means lower exposure to the anti-inflammatory effects of cortisol
for victimized children. Additional analyses are necessary to test
other potential psychosocial and biological mechanisms for this
observed effect.
Pure bullies displayed lower levels of CRP when followed into
adulthood. Longitudinal studies of early life experiences and
biological markers have focused almost exclusively on adversity.
This finding may seem surprising, because two groups of chil-
dren/adolescents often were lumped together in previous re-
search as “bullies,” although they are distinct in many features. If
considered separately, one group of bullies—those who also are
bullied themselves—the bully–victims have the worst long-term
emotional problems and poor health outcomes (1, 2). They most
closely resemble those with conduct problems (38, 39). In con-
trast, there is evidence that those who perpetrate only, pure
bullies, gain benefits from bullying others without incurring costs
and may be healthier than their peers, emotionally and physically
(6, 8). As such, analyses that group bully–victims with pure
bullies (as is the case in analyses of children with conduct dis-
order) may be mixing distinct phenotypes. Our findings also are
consistent with studies showing lower inflammation rates for
individuals with higher SES (23) and studies with nonhuman
primates showing health benefits for those higher in the social
hierarchy (40). The clear implication of these findings is that both
ends of the continuum of social status are important for in-
flammation levels and health status.
Strengths and Limitations. The Great Smoky Mountains Study
has several strengths besides its longitudinal, prospective design:
Table 2. Associations between CRP and bullying involvement within childhood/adolescence (ages 9–16)
Simple Adjusted for CRP-related covariates Adjusted for bullying-related covariates
Bully status β (SE) P Sig. covariates β (SE) P Sig. covariates β (SE) P Sig. covariates
Recent status
Pure bully 0.07 (0.05) 0.11 Prior CRP 0.05 (0.05) 0.25 Prior CRP, race, BMI,
med. use
0.08 (0.05) 0.12 Prior CRP, race,
family dysfunction
Pure victim 0.03 (0.02) 0.19 Prior CRP 0.03 (0.02) 0.22 Prior CRP, race, BMI,
med. use
0.04 (0.02) 0.10 Prior CRP, race,
family dysfunction
Bully–victim 0.06 (0.07) 0.35 Prior CRP 0.02 (0.07) 0.78 Prior CRP, race, BMI,
med. use
0.07 (0.07) 0.32 Prior CRP, race,
family dysfunction
Cumulative
Pure bully 0.01 (0.01) 0.63 Prior CRP 0.00 (0.01) 0.87 Prior CRP, race, BMI,
med. use
0.01 (0.02) 0.58 Prior CRP, race, anxiety,
family dysfunction
Pure victim 0.02 (0.01) 0.01 Prior CRP 0.02 (0.01) 0.01 Prior CRP, race, BMI,
med. use
0.02 (0.01) 0.008 Prior CRP, race, anxiety,
family dysfunction
Bully–victim 0.05 (0.05) 0.32 Prior CRP 0.03 (0.06) 0.66 Prior CRP, race, BMI,
med. use
0.05 (0.06) 0.41 Prior CRP, race, anxiety,
family dysfunction
All models were tested using weighted linear regression. Simple models include current status on the bullying variables and status of CRP at the prior
observation. CRP-related covariates also included the following: sex, age, race/ethnicity, time since last interview, BMI, recent nicotine use, recent alcohol use,
recent drug use, recent medication use, health ailments, and low SES. Bullying-related covariates include sex, race/ethnicity, low SES, family instability, family
dysfunction, maltreatment, depressive disorders, anxiety disorders, disruptive behavior disorders, or substance disorders. Boldface values are significant at the
P < 0.05 level.
Fig. 1. Adjusted mean childhood/adolescent CRP levels (milligrams per liter)
based on cumulative exposure to being bullied. These values are adjusted for
baseline CRP levels as well as other CRP-related covariates. All analyses used
robust SEs to account for repeated observations.
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a population-based design that minimizes selection biases; bul-
lying variables assessed repeatedly with structured interviews;
repeated collection of blood spots, allowing subjects to provide
up to nine values of CRP across 12 y; and assessment of a wide
range of domains, allowing us to control for covariates of bul-
lying and CRP. However, the study also has limitations: the
sample is not representative of the US population, with Native
Americans overrepresented and African Americans and Latinos
underrepresented. The time between any two assessments was
never less than a year, yet both CRP levels and bullying in-
volvement may vary over shorter periods. Finally, adult follow-up
was limited to those who were available for in-person interviews
and agreed to provide blood spots.
Conclusion
Being bullied is known to have adverse effects on psychological
and social development, but it is increasingly being recast as
similar to family maltreatment in its potential to disrupt both
mental and physical functioning across the lifespan (1, 2). In
contrast, bullies experience few downsides and reap biological
advantages of increased social status. Social status and dis-
ruptions to one’s status may play a central role in physical health
functioning through effects on chronic low-grade inflammation,
and these effects may persist for decades. Our findings suggest
that this mechanism may be a key target for efforts to reduce risk
for a bevy of age-related diseases and to promote optimal psy-
chological and physical health functioning.
Materials and Methods
Participants. The Great Smoky Mountains Study is a longitudinal study of the
development of psychiatric disorders and the need for mental health services
in rural and urban youth (41, 42). A representative sample of three cohorts
of children, ages 9, 11, and 13 at intake, was recruited from 11 counties in
western North Carolina. Potential participants were selected from the
population of some 12,000 children by using a household equal probability,
accelerated cohort design. All children scoring above a predetermined cut
point (the top 25% of the total scores) on a behavioral screener, plus a 1-in-
10 random sample of the remaining 75% of the total scores, were recruited
for detailed interviews. This approach oversamples those at risk for psychi-
atric problems for the purpose of estimating prevalence rates for uncommon
psychiatric disorders. All subjects were assigned a weight inversely pro-
portional to their probability of selection, so all results are representative of
the population from which the sample was drawn and not biased from the
oversampling procedure. About 8% of the area residents and the sample
were African American, less than 1% were Hispanic, and 3% were American
Indian. Of all subjects recruited, 80% (n = 1,420) agreed to participate.
Subjects were assessed annually to age 16, then again at ages 19 and 21.
Across all waves, participation rates averaged 84% (range: 74–94%).
Procedures. The parent (biological mother for 83% of interviews) and subject
were interviewed by trained interviewers separately until the subject was 16,
after which only the subjects were interviewed. Before the interviews began,
parent and child signed informed consent forms approved by the Duke
University Medical Center Institutional Review Board. Each parent and child
received an honorarium for their participation.
Using a previously described procedure (43), blood samples were obtained
at the beginning of each in-person assessment as follows: two finger-prick
samples (yielding 10 spots total per visit) were collected at 20-min intervals,
applied to standardized collection paper, immediately refrigerated upon
drying, and express shipped (without refrigeration) to the laboratory within
2 wk of collection. Samples then were stored at −28 °C until they were
assayed. This protocol is consistent with the rigorous quality control program
Table 3. Associations between childhood bullying involvement and adult CRP levels (ages 19 and 21)
Simple Adjusted for CRP-related covariates Adjusted for bullying-related covariates
Bully status β (SE) P Sig. covariates β (SE) P Sig. covariates β (SE) P Sig. covariates
Childhood status
Pure bully −0.13 (0.04) 0.002 Prior CRP −0.09 (0.04) 0.01 Prior CRP, sex, race,
BMI, med. use
−0.10 (0.04) 0.01 Prior CRP, sex,
race, SES
Pure victim 0.07 (0.04) 0.10 Prior CRP 0.09 (0.04) 0.02 Prior CRP, sex, race,
BMI, med. use
0.07 (0.03) 0.02 Prior CRP, sex,
race, SES
Bully–victim −0.03 (0.06) 0.68 Prior CRP −0.08 (0.05) 0.09 Prior CRP, sex, race,
BMI, med. use
−0.03 (0.06) 0.56 Prior CRP, sex,
race, SES
Cumulative
Pure bully −0.06 (0.04) 0.08 Prior CRP −0.06 (0.03) 0.04 Prior CRP, sex, race,
BMI, med. use
−0.05 (0.03) 0.14 Prior CRP, sex, race,
poverty, dysfunction
Pure victim 0.04 (0.03) 0.08 Prior CRP 0.05 (0.03) 0.06 Prior CRP, sex, race,
BMI, med. use
0.05 (0.02) 0.01 Prior CRP, sex, race,
poverty, dysfunction
Bully–victim −0.04 (0.09) 0.62 Prior CRP −0.04 (0.07) 0.58 Prior CRP, sex, race,
BMI, med. use
0.05 (0.07) 0.44 Prior CRP, sex, race,
poverty, dysfunction
All models were tested using weighted linear regression. Simple models include current status on the bullying variables and status of CRP at the prior
observation. CRP-related covariates include the following: sex, age, time since last interview, BMI, recent nicotine use, recent alcohol use, recent drug use,
recent medication use, health ailments, and low SES. Bullying-related covariates controlled for childhood/adolescent covariates of bullying status. These
included sex, low SES, family instability, family dysfunction, maltreatment, depressive disorders, anxiety disorders, disruptive behavior disorders, or substance
disorders. Boldface values are significant at the P < 0.05 level.
Fig. 2. Adjusted mean young adult CRP levels (milligrams per liter) based on
childhood/adolescent bullying status. These values are adjusted for baseline
CRP levels as well as other CRP-related covariates. All analyses used robust
SEs to account for repeated observations.
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developed for newborn screening programs (44) and has been used in sev-
eral epidemiologic studies involving blood spot CRP measures (45, 46).
Assessment. Bullying involvement. At each assessment between ages 9 and 16,
the child and his or her parent reported on whether the child had been
bullied/teased or had bullied others in the 3 mo immediately before the
interview as part of the Child and Adolescent Psychiatric Assessment (CAPA)
(47). Being bullied or bullying others was counted if reported by either the
parent or the child. If the informant reported that the subject had been
bullied or had bullied others, then the informant was asked separately how
often the bullying occurred in the prior 3 mo in the following three settings:
home, school, and the community. The focus in the current paper is on peer
bullying in the school context only. Subjects were categorized as only bul-
lying others (pure bullies), only being bullied (pure victims), both bullying
others and being bullied (bully–victims), or neither bullying others nor being
bullied. Parent and child agreement (kappa = 0.24) was similar to that of
other bullying measures (48, 49). Although this value may seem low, a large
meta-analysis of parent and self-report of behavioral and emotional func-
tioning shows similar concordance levels (50).
CRP. Our assay for CRP in whole-blood spots was a biotin–streptavidin-based
immunofluorometric system improving on a previously published method
(51). One assay was completed for each subject at each observation. A val-
idation study was performed with matched serum and blood spot samples
assayed for CRP (n = 38). As has been reported for many other analytes,
including CRP (43, 51, 52), a close linear correlation was identified between
serum and blood spot CRP values (n = 29; R2 = 0.98; P < 0.0001). Serum
equivalents therefore were calculated by using the following algorithm
based on the serum–blood spot regression: serum [high sensitivity C-reactive
protein (hsCRP)] = 1.38*(blood spot CRP value) – 0.97. Blood spot CRP
measures have been used in several epidemiologic studies (45, 46, 53).
Observations with values above 10 mg/L indicate frank infection and were
removed from statistical analysis (n = 109 from a total of 6,000 obser-
vations), whereas values below that index the extent of chronic low-
grade systemic inflammation associated with cardiovascular and meta-
bolic risk (54).
CRP-related covariates. Variables included as covariates were those associated
with variation in CRP levels (13, 55, 56) or those used as covariates in other
longitudinal studies involving CRP (57, 58). These variables included age, sex,
race, BMI, medication use, substance use, low SES, and recent physical ail-
ments. BMI was calculated from interviewer-assessed weight and height
measurements completed at each assessment. The substance use assessment
of the CAPA and Young Adult Psychiatric Assessment (YAPA) interviews
evaluates current nicotine, alcohol, and illicit drug use. Dichotomous varia-
bles were included to indicate recent use of these substances. A physical
health problems survey adapted from the Centers for Disease Control and
Prevention National Health Interview Survey Child Supplement (1988) was
administered at all interviews to assess 39 common ailments (e.g., diabetes,
anemia, mononucleosis). A binary variable indicating any health ailments
within the past 12 mo was used for all analyses. Analyses also were tested by
using the following separate health categories: atopic (e.g., food/digestive
allergy, asthma, and respiratory allergy), injuries, infections (tonsillitis, ear
infection, frequent diarrhea or colitis, and urinary tract infections), and
chronic diseases (e.g., diabetes, epilepsy, cancer, and chronic heart disease).
Medication use within the prior year also was assessed from the Child and
Adolescent Services Assessment (59). That interview focused on psychotropic
medications, but it also looked at prescribed medications not related to
psychiatric problems. All analyses were tested using a broad-based medica-
tion use variable as well as categories for individual medication groups (e.g.,
antidepressant, stimulant, and other prescribed medications). Low SES coded
whether the subject’s family displayed any two of the following three
indicators: income below the federal poverty line, low parental educational
attainment, and low parental occupational status. Additional physiological
covariates studied with CRP in older samples at risk for cardiovascular
problems (e.g., blood pressure, lipids, or insulin) were not assessed.
Bullying-related covariates. To clarify that bullying involvement is an in-
dependent risk factor for CRP, it was necessary to account for preexisting
family and individual factors. All childhood psychiatric and family hardship
variables were assessed by parent and self-report using the CAPA (47).
Childhood psychiatric variables included any anxiety disorder, any depressive
disorder, any behavioral disorder (conduct disorder, attention-deficit hy-
peractivity disorder, and oppositional defiant disorder), and any substance
abuse or dependence. See ref. 60 for additional details. Four types of family
hardships were assessed: low SES, unstable family structure, family dys-
function, and maltreatment. A full description of these variables is available
from ref. 2.
Analytic Framework. CRP values were positively skewed and were log10-
transformed after scaling for nonnegative values by adding 1. All models
used SAS PROC GENMOD to run weighted linear regression models with
robust variance (sandwich-type) estimates derived from generalized es-
timating equations to adjust the SEs for the stratified design and re-
peated observations.
ACKNOWLEDGMENTS. This work was supported by the National Institute
of Mental Health (MH63970, MH63671, MH48085, and MH080230), the
National Institute on Drug Abuse (DA/MH11301 and DA023026), the National
Alliance for Research on Schizophrenia and Depression (Early Career Award to
W.E.C.), the William T. Grant Foundation, and the Economic and Social
Research Council in the United Kingdom (ES/K003593/1).
1. Wolke D, Copeland WE, Angold A, Costello EJ (2013) Impact of bullying in child-
hood on adult health, wealth, crime, and social outcomes. Psychol Sci 24(10):
1958–1970.
2. Copeland WE, Wolke D, Angold A, Costello EJ (2013) Adult psychiatric outcomes of
bullying and being bullied by peers in childhood and adolescence. JAMA Psychiatry
70(4):419–426.
3. Sourander AMD, et al. (2005) Childhood predictors of psychiatric disorders among
boys: A prospective community-based follow-up study from age 8 years to early
adulthood. J Am Acad Child Adolesc Psychiatry 44(8):756–767.
4. Winsper C, Lereya T, Zanarini M, Wolke D (2012) Involvement in bullying and suicide-
related behavior at 11 years: A prospective birth cohort study. J Am Acad Child
Adolesc Psychiatry 51(3):271, e3.
5. Gini G, Pozzoli T (2009) Association between bullying and psychosomatic problems:
A meta-analysis. Pediatrics 123(3):1059–1065.
6. Wolke D, Woods S, Bloomfield L, Karstadt L (2001) Bullying involvement in primary
school and common health problems. Arch Dis Child 85(3):197–201.
7. Forero R, McLellan L, Rissel C, Bauman A (1999) Bullying behaviour and psychosocial
health among school students in New South Wales, Australia: Cross sectional survey.
BMJ 319(7206):344–348.
8. Kumpulainen K, et al. (1998) Bullying and psychiatric symptoms among elementary
school-age children. Child Abuse Negl 22(7):705–717.
9. Danese A, et al. (2011) Biological embedding of stress through inflammation pro-
cesses in childhood. Mol Psychiatry 16(3):244–246.
10. Steptoe A, Hamer M, Chida Y (2007) The effects of acute psychological stress on
circulating inflammatory factors in humans: a review and meta-analysis. Brain Behav
Immun 21(7):901–912.
11. Moyna NM, et al. (1999) Relation between aerobic fitness level and stress induced
alterations in neuroendocrine and immune function. Int J Sports Med 20(2):136–141.
12. Alley DE, et al. (2006) Socioeconomic status and C-reactive protein levels in the US
population: NHANES IV. Brain Behav Immun 20(5):498–504.
13. O’Connor M-F, et al. (2009) To assess, to control, to exclude: Effects of biobehavioral
factors on circulating inflammatory markers. Brain Behav Immun 23(7):887–897.
14. Dai J, et al. (2008) Adherence to the mediterranean diet is inversely associated with
circulating interleukin-6 among middle-aged men: A twin study. Circulation 117(2):
169–175.
15. Raison CL, Capuron L, Miller AH (2006) Cytokines sing the blues: Inflammation and
the pathogenesis of depression. Trends Immunol 27(1):24–31.
16. Dantzer R, O’Connor JC, Freund GG, Johnson RW, Kelley KW (2008) From in-
flammation to sickness and depression: When the immune system subjugates the
brain. Nat Rev Neurosci 9(1):46–56.
17. Kaptoge S, et al.; Emerging Risk Factors Collaboration (2010) C-reactive protein
concentration and risk of coronary heart disease, stroke, and mortality: An individual
participant meta-analysis. Lancet 375(9709):132–140.
18. Shah T, et al. (2009) Critical appraisal of CRP measurement for the prediction of
coronary heart disease events: New data and systematic review of 31 prospective
cohorts. Int J Epidemiol 38(1):217–231.
19. Tamakoshi K, et al. (2003) The metabolic syndrome is associated with elevated cir-
culating C-reactive protein in healthy reference range, a systemic low-grade in-
flammatory state. Int J Obes Relat Metab Disord 27(4):443–449.
20. Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM (2001) C-reactive protein, in-
terleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 286(3):327–334.
21. Ridker PM, Buring JE, Cook NR, Rifai N (2003) C-reactive protein, the metabolic syn-
drome, and risk of incident cardiovascular events: An 8-year follow-up of 14 719
initially healthy American women. Circulation 107(3):391–397.
22. Reijntjes A, et al. (2013) Costs and benefits of bullying in the context of the
peer group: A three wave longitudinal analysis. J Abnorm Child Psychol 41(8):
1217–1229.
23. Jousilahti P, Salomaa V, Rasi V, Vahtera E, Palosuo T (2003) Association of markers of
systemic inflammation, C reactive protein, serum amyloid A, and fibrinogen, with
socioeconomic status. J Epidemiol Community Health 57(9):730–733.
24. Loucks EB, et al. (2006) Association of educational level with inflammatory markers in
the Framingham Offspring Study. Am J Epidemiol 163(7):622–628.
25. Koster A, et al.; Health ABC Study (2006) Association of inflammatory markers with
socioeconomic status. J Gerontol A Biol Sci Med Sci 61(3):284–290.
Copeland et al. PNAS Early Edition | 5 of 6
PS
YC
H
O
LO
G
IC
A
L
A
N
D
CO
G
N
IT
IV
E
SC
IE
N
CE
S
26. Shanahan L, et al. (2013) Sex-differentiated changes in C-reactive protein from ages
9 to 21: The contributions of BMI and physical/sexual maturation. Psychoneur-
oendocrinology 38(10):2209–2217.
27. Danese A, Pariante CM, Caspi A, Taylor A, Poulton R (2007) Childhood maltreatment
predicts adult inflammation in a life-course study. Proc Natl Acad Sci USA 104(4):
1319–1324.
28. Danese A, et al. (2008) Elevated inflammation levels in depressed adults with a history
of childhood maltreatment. Arch Gen Psychiatry 65(4):409–415.
29. Finkelhor D, Ormrod RK, Turner HA (2007) Polyvictimization and trauma in a national
longitudinal cohort. Dev Psychopathol 19(1):149–166.
30. Radford L, Corral S, Bradley C, Fisher HL (2013) The prevalence and impact of child
maltreatment and other types of victimization in the UK: Findings from a population
survey of caregivers, children and young people and young adults. Child Abuse Negl
37(10):801–813.
31. Knack JM, Jensen-Campbell LA, Baum A (2011) Worse than sticks and stones? Bullying is
associated with altered HPA axis functioning and poorer health. Brain Cogn 77(2):183–190.
32. Hansen ÅM, et al. (2006) Bullying at work, health outcomes, and physiological stress
response. J Psychosom Res 60(1):63–72.
33. Rudolph KD, Troop-Gordon W, Granger DA (2010) Peer victimization and aggression:
Moderation by individual differences in salivary cortisol and alpha-amylase. J Abnorm
Child Psychol 38(6):843–856.
34. Ouellet-Morin I, et al. (2013) Increased serotonin transporter gene (SERT) DNA
methylation is associated with bullying victimization and blunted cortisol response to
stress in childhood: A longitudinal study of discordant monozygotic twins. Psychol
Med 43(9):1813–1823.
35. Ouellet-Morin I, et al. (2011) A discordant monozygotic twin design shows blunted
cortisol reactivity among bullied children. J Am Acad Child Adolesc Psychiatry 50(6):
574–582, e3.
36. Ouellet-Morin I, et al. (2011) Blunted cortisol responses to stress signal social and
behavioral problems among maltreated/bullied 12-year-old children. Biol Psychiatry
70(11):1016–1023.
37. Hamilton LD, Newman ML, Delville CL, Delville Y (2008) Physiological stress response
of young adults exposed to bullying during adolescence. Physiol Behav 95(5):617–624.
38. Juvonen J, Graham S, Schuster MA (2003) Bullying among young adolescents: The
strong, the weak, and the troubled. Pediatrics 112(6 Pt 1):1231–1237.
39. Jansen DE, Veenstra R, Ormel J, Verhulst FC, Reijneveld SA (2011) Early risk factors for
being a bully, victim, or bully/victim in late elementary and early secondary education.
The longitudinal TRAILS study. BMC Public Health 11(1):440.
40. Sapolsky RM (2005) The influence of social hierarchy on primate health. Science
308(5722):648–652.
41. Costello EJ, et al. (1996) The Great Smoky Mountains Study of Youth. Goals, design,
methods, and the prevalence of DSM-III-R disorders.Arch Gen Psychiatry 53(12):1129–1136.
42. Costello EJ, Mustillo S, Erkanli A, Keeler G, Angold A (2003) Prevalence and de-
velopment of psychiatric disorders in childhood and adolescence. Arch Gen Psychiatry
60(8):837–844.
43. Worthman CM, Stallings JF (1997) Hormone measures in finger-prick blood spot
samples: New field methods for reproductive endocrinology. Am J Phys Anthropol
104(1):1–21.
44. Mei JV, Alexander JR, Adam BW, Hannon WH (2001) Use of filter paper for the col-
lection and analysis of human whole blood specimens. J Nutr 131(5):1631S–1636S.
45. McDade TW, Hawkley LC, Cacioppo JT (2006) Psychosocial and behavioral predictors
of inflammation in middle-aged and older adults: The Chicago health, aging, and
social relations study. Psychosom Med 68(3):376–381.
46. Williams SR, McDade TW (2009) The use of dried blood spot sampling in the national
social life, health, and aging project. J Gerontol B Psychol Sci Soc Sci 64(Suppl 1):
i131–i136.
47. Angold A, Costello EJ (2000) The Child and Adolescent Psychiatric Assessment (CAPA).
J Am Acad Child Adolesc Psychiatry 39(1):39–48.
48. Schreier A, et al. (2009) Prospective study of peer victimization in childhood and
psychotic symptoms in a nonclinical population at age 12 years. Arch Gen Psychiatry
66(5):527–536.
49. Rønning JA, et al. (2009) Cross-informant agreement about bullying and victimization
among eight-year-olds: Whose information best predicts psychiatric caseness 10-15
years later? Soc Psychiatry Psychiatr Epidemiol 44(1):15–22.
50. Achenbach TM, McConaughy SH, Howell CT (1987) Child/adolescent behavioral and
emotional problems: Implications of cross-informant correlations for situational
specificity. Psychol Bull 101(2):213–232.
51. McDade TW, Burhop J, Dohnal J (2004) High-sensitivity enzyme immunoassay for
C-reactive protein in dried blood spots. Clin Chem 50(3):652–654.
52. McDade TW, et al. (2000) Epstein-Barr virus antibodies in whole blood spots: A
minimally invasive method for assessing an aspect of cell-mediated immunity. Psy-
chosom Med 62:560–568.
53. McDade TW, et al. (2005) Predictors of C-reactive protein in Tsimane’ 2 to 15 year-olds
in lowland Bolivia. Am J Phys Anthropol 128(4):906–913.
54. Pearson TA, et al.; Centers for Disease Control and Prevention; American Heart As-
sociation (2003) Markers of inflammation and cardiovascular disease: Application to
clinical and public health practice: A statement for healthcare professionals from the
Centers for Disease Control and Prevention and the American Heart Association.
Circulation 107(3):499–511.
55. Woodward M, Rumley A, Lowe GDO, Tunstall-Pedoe H (2003) C-reactive protein:
Associations with haematological variables, cardiovascular risk factors and prevalent
cardiovascular disease. Br J Haematol 122(1):135–141.
56. Elovainio M, et al.; Cardiovascular Risk in Young Finns Study (2006) Depressive
symptoms and C-reactive protein: The Cardiovascular Risk in Young Finns Study.
Psychol Med 36(6):797–805.
57. Gimeno D, et al. (2009) Associations of C-reactive protein and interleukin-6 with
cognitive symptoms of depression: 12-year follow-up of the Whitehall II study. Psy-
chol Med 39(3):413–423.
58. Stewart JC, Rand KL, Muldoon MF, Kamarck TW (2009) A prospective evaluation of
the directionality of the depression-inflammation relationship. Brain Behav Immun
23(7):936–944.
59. Ascher BH, Farmer EMZ, Burns BJ, Angold A (1996) The Child and Adolescent Services
Assessment (CASA): Description and psychometrics. J Emot Behav Disord 4(1):12–20.
60. Copeland W, Shanahan L, Costello EJ, Angold A (2011) Cumulative prevalence
of psychiatric disorders by young adulthood: A prospective cohort analysis from
the Great Smoky Mountains Study. J Am Acad Child Adolesc Psychiatry 50(3):252–261.
6 of 6 | www.pnas.org/cgi/doi/10.1073/pnas.1323641111 Copeland et al.
Supporting Information
Copeland et al. 10.1073/pnas.1323641111
Table S1. Associations between CRP and bullying involvement within childhood/adolescence (ages 9–16; parent report)
Simple Adjusted for CRP-related covariates Adjusted for bullying-related covariates
Bully status β (SE) P Sig. covariates β (SE) P Sig. covariates β (SE) P Sig. covariates
Recent status
Bully 0.06 (0.05) 0.23 Prior CRP 0.03 (0.05) 0.58 Prior CRP, race, BMI,
med. use
0.05 (0.05) 0.27 Prior CRP, race,
family dysfunction
Victim 0.01 (0.02) 0.70 Prior CRP 0.01 (0.02) 0.92 Prior CRP, race, BMI,
med. use
0.02 (0.02) 0.41 Prior CRP, race,
family dysfunction
Bully–victim 0.08 (0.09) 0.36 Prior CRP 0.00 (0.08) 0.97 Prior CRP, race, BMI,
med. use
0.08 (0.09) 0.37 Prior CRP, race,
family dysfunction
Cumulative
Bully 0.03 (0.02) 0.12 Prior CRP 0.02 (0.02) 0.14 Prior CRP, BMI, med. use 0.01 (0.02) 0.43 Prior CRP, race, anxiety,
family dysfunction
Victim 0.03 (0.01) 0.02 Prior CRP 0.01 (0.01) 0.25 Prior CRP, BMI, med. use 0.03 (0.01) 0.01 Prior CRP, race, anxiety,
family dysfunction
Bully–victim 0.05 (0.03) 0.13 Prior CRP 0.02 (0.03) 0.52 Prior CRP, BMI, med. use 0.04 (0.03) 0.20 Prior CRP, race, anxiety,
family dysfunction
All models were tested using weighted linear regression. Simple models include current status on the bullying variables and status of C-reactive protein (CRP)
at the prior observation. CRP-related covariates also included the following: sex, age, time since last interview, body mass index (BMI), recent nicotine use,
recent alcohol use, recent drug use, recent medication use, health ailments, and low socioeconomic status (SES). Bullying-related covariates include sex, low SES,
family instability, family dysfunction, maltreatment, depressive disorders, anxiety disorders, disruptive behavior disorders, or substance disorders. Boldface
refers to findings significant at P < 0.05.
Table S2. Associations between CRP and bullying involvement within childhood/adolescence (ages 9–16; child report)
Simple Adjusted for CRP-related covariates Adjusted for bullying-related covariates
Bully status β (SE) P Sig. covariates β (SE) p Sig. covariates β (SE) p Sig. covariates
Recent status
Bully 0.10 (0.09) 0.23 Prior CRP 0.09 (0.08) 0.27 Prior CRP, race,
BMI, med. use
0.10 (0.10) 0.32 Prior CRP, race,
family dysfunction
Victim 0.06 (0.03) 0.06 Prior CRP 0.06 (0.03) 0.07 Prior CRP, race,
BMI, med. use
0.07 (0.03) 0.04 Prior CRP, race,
family dysfunction
Bully–victim −0.05 (0.01) <0.001 Prior CRP −0.04 (0.02) 0.06 Prior CRP, race,
BMI, med. use
−0.06 (0.03) 0.07 Prior CRP, race,
family dysfunction
Cumulative
Bully −0.01 (0.03) 0.75 Prior CRP −0.03 (0.02) 0.23 Prior CRP, BMI,
med. use
−0.02 (0.03) 0.43 Prior CRP, race, anxiety,
family dysfunction
Victim 0.02 (0.01) 0.06 Prior CRP 0.02 (0.01) 0.04 Prior CRP, BMI,
med. use
0.02 (0.01) 0.06 Prior CRP, race, anxiety,
family dysfunction
Bully–victim −0.01 (0.05) 0.89 Prior CRP −0.01 (0.04) 0.91 Prior CRP, BMI,
med. use
−0.02 (0.05) 0.78 Prior CRP, race, anxiety,
family dysfunction
All models were tested using weighted linear regression. Simple models include current status on the bullying variables and status of C-reactive protein (CRP)
at the prior observation. CRP-related covariates also included the following: sex, age, time since last interview, body mass index (BMI), recent nicotine use,
recent alcohol use, recent drug use, recent medication use, health ailments, and low socioeconomic status (SES). Bullying-related covariates include sex, low SES,
family instability, family dysfunction, maltreatment, depressive disorders, anxiety disorders, disruptive behavior disorders, or substance disorders. Boldface
refers to findings significant at P < 0.05.
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Table S3. Associations between childhood bullying involvement and adult CRP levels (ages 19 and 21; parent report)
Simple Adjusted for CRP-related covariates
Adjusted for bullying-related
covariates
Bully status β (SE) P Sig. covariates β (SE) P Sig. covariates β (SE) P Sig. covariates
Childhood status
Bully −0.16 (0.04) 0.04 Prior CRP −0.14 (0.03) <0.001 Prior CRP, sex, race
BMI, med. use
−0.16 (0.05) <0.001 Prior CRP, sex,
race, SES
Victim 0.02 (0.05) 0.71 Prior CRP 0.02 (0.04) 0.64 Prior CRP, sex, race
BMI, med. use
0.02 (0.04) 0.68 Prior CRP, sex,
race, SES
Bully–victim 0.11 (0.05) 0.02 Prior CRP 0.03 (0.06) 0.62 Prior CRP, sex, race
BMI, med. use
0.10 (0.05) 0.09 Prior CRP, sex,
race, SES
Cumulative
Bully −0.12 (0.03) <0.001 Prior CRP −0.10 (0.03) <0.001 Prior CRP, sex, race,
BMI, med. use
−0.12 (0.03) <0.001 Prior CRP, sex,
race, SES
Victim 0.02 (0.03) 0.57 Prior CRP 0.01 (0.02) 0.52 Prior CRP, sex, race,
BMI, med. use
0.02 (0.02) 0.44 Prior CRP, sex,
race, SES
Bully–victim 0.07 (0.03) 0.02 Prior CRP 0.03 (0.03) 0.40 Prior CRP, sex, race,
BMI, med. use
0.06 (0.04) 0.16 Prior CRP, sex,
race, SES
All models were tested by using weighted linear regression. Simple models include current status on the bullying variables and status of C-reactive protein
(CRP) at the prior observation. CRP-related covariates include the following: sex, age, time since last interview, body mass index (BMI), recent nicotine use,
recent alcohol use, recent drug use, recent medication use, health ailments, and low socioeconomic status (SES). Bullying-related covariates controlled for
childhood/adolescent covariates of bullying status. These included sex, low SES, family instability, family dysfunction, maltreatment, depressive disorders,
anxiety disorders, disruptive behavior disorders, or substance disorders. Boldface refers to findings significant at P < 0.05.
Table S4. Associations between childhood bullying involvement and adult CRP levels (ages 19 and 21; child report)
Simple Adjusted for CRP-related covariates Adjusted for bullying-related covariates
Bully status β (SE) P Sig. covariates β (SE) P Sig. covariates β (SE) P Sig. covariates
Childhood status
Bully −0.07 (0.08) 0.86 Prior CRP −0.03 (0.06) 0.58 Prior CRP, sex, race,
BMI, med. use
−0.01 (0.06) 0.98 Prior CRP, sex, race,
SES, family dysfunction
Victim 0.07 (0.04) 0.10 Prior CRP 0.07 (0.05) 0.14 Prior CRP, sex, race,
BMI, med. use
0.08 (0.03) 0.03 Prior CRP, sex, race,
SES, family dysfunction
Bully–victim −0.01 (0.08) 0.43 Prior CRP −0.11 (0.08) 0.12 Prior CRP, sex, race,
BMI, med. use
−0.06 (0.07) 0.48 Prior CRP, sex, race,
SES, family dysfunction
Cumulative
Bully −0.04 (0.06) 0.62 Prior CRP −0.03 (0.05) 0.57 Prior CRP, sex, race,
BMI, med. use
−0.01 (0.04) 0.92 Prior CRP, sex, race,
poverty, dysfunction
Victim 0.06 (0.04) 0.13 Prior CRP 0.07 (0.04) 0.10 Prior CRP, sex, race,
BMI, med. use
0.07 (0.03) 0.02 Prior CRP, sex, race,
poverty, dysfunction
Bully–victim −0.02 (0.05) 0.76 Prior CRP −0.07 (0.05) 0.12 Prior CRP, sex, race,
BMI, med. use
−0.04 (0.03) 0.28 Prior CRP, sex, race,
poverty, dysfunction
All models were tested by using weighted linear regression. Simple models include current status on the bullying variables and status of C-reactive protein
(CRP) at the prior observation. CRP-related covariates include the following: sex, age, time since last interview, body mass index (BMI), recent nicotine use,
recent alcohol use, recent drug use, recent medication use, health ailments, and low socioeconomic status (SES). Bullying-related covariates controlled for
childhood/adolescent covariates of bullying status. These included sex, low SES, family instability, family dysfunction, maltreatment, depressive disorders,
anxiety disorders, disruptive behavior disorders, or substance disorders. Boldface refers to findings significant at P < 0.05.
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Table S5. Associations between childhood bullying involvement and adult CRP levels by age (ages 19 and 21)
Simple Adjusted for CRP-related covariates Adjusted for bullying-related covariates
Ages, y β (SE) P Sig. covariates β (SE) P Sig. covariates β (SE) P Sig. covariates
9–13
Bully −0.08 (0.06) 0.28 Prior CRP −0.07 (0.05) 0.24 Prior CRP, sex, race,
BMI, med. use
−0.09 (0.06) 0.19 Prior CRP, sex, race,
SES, family dysfunction
Victim 0.07 (0.04) 0.09 Prior CRP 0.09 (0.04) 0.02 Prior CRP, sex, race,
BMI, med. use
0.08 (0.03) 0.01 Prior CRP, sex, race,
SES, family dysfunction
Bully–victim −0.07 (0.07) 0.32 Prior CRP −0.10 (0.06) 0.09 Prior CRP, sex, race,
BMI, med. use
−0.08 (0.05) 0.13 Prior CRP, sex, race,
SES, family dysfunction
14–16
Bully −0.11 (0.05) 0.04 Prior CRP −0.10 (0.04) 0.006 Prior CRP, sex, race,
BMI, med. use
−0.05 (0.04) 0.27 Prior CRP, sex, race,
poverty, dysfunction
Victim 0.02 (0.05) 0.89 Prior CRP 0.02 (0.04) 0.61 Prior CRP, sex, race,
BMI, med. use
0.02 (0.04) 0.66 Prior CRP, sex, race,
poverty, dysfunction
Bully–victim 0.03 (0.07) 0.75 Prior CRP −0.05 (0.06) 0.40 Prior CRP, sex, race,
BMI, med. use
−0.02 (0.06) 0.70 Prior CRP, sex, race,
poverty, dysfunction
All models were tested by using weighted linear regression. Simple models include current status on the bullying variables and status of C-reactive protein
(CRP) at the prior observation. CRP-related covariates include the following: sex, age, time since last interview, body mass index (BMI), recent nicotine use,
recent alcohol use, recent drug use, recent medication use, health ailments, and low socioeconomic (SES). Bullying-related covariates controlled for childhood/
adolescent covariates of bullying status. These included sex, low SES, family instability, family dysfunction, maltreatment, depressive disorders, anxiety
disorders, disruptive behavior disorders, or substance disorders.
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